Centene Corporation (CNC)
NYSE: CNC · Real-Time Price · USD
38.34
-0.51 (-1.31%)
At close: Dec 5, 2025, 4:00 PM EST
38.45
+0.11 (0.29%)
After-hours: Dec 5, 2025, 7:00 PM EST
Centene Market Cap
Centene has a market cap or net worth of $18.84 billion as of December 5, 2025. Its market cap has decreased by -36.55% in one year.
Market Cap
18.84B
Enterprise Value
19.37B
1-Year Change
-36.55%
Ranking
Category
Stock Price
$38.34
Market Cap Chart
Since December 13, 2001, Centene's market cap has increased from $173.20M to $18.84B, an increase of 10,780.37%. That is a compound annual growth rate of 21.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 19.10B | -37.57% |
| Dec 31, 2024 | 30.58B | -22.85% |
| Dec 29, 2023 | 39.64B | -14.63% |
| Dec 30, 2022 | 46.44B | -3.41% |
| Dec 31, 2021 | 48.08B | 38.14% |
| Dec 31, 2020 | 34.81B | 33.79% |
| Dec 31, 2019 | 26.02B | 9.87% |
| Dec 31, 2018 | 23.68B | 36.01% |
| Dec 29, 2017 | 17.41B | 80.27% |
| Dec 30, 2016 | 9.66B | 23.10% |
| Dec 31, 2015 | 7.84B | 28.76% |
| Dec 31, 2014 | 6.09B | 88.70% |
| Dec 31, 2013 | 3.23B | 52.51% |
| Dec 31, 2012 | 2.12B | 6.14% |
| Dec 30, 2011 | 1.99B | 52.18% |
| Dec 31, 2010 | 1.31B | 36.35% |
| Dec 31, 2009 | 961.30M | 13.67% |
| Dec 31, 2008 | 845.70M | -29.19% |
| Dec 31, 2007 | 1.19B | 12.60% |
| Dec 29, 2006 | 1.06B | -5.45% |
| Dec 30, 2005 | 1.12B | -3.60% |
| Dec 31, 2004 | 1.16B | 107.10% |
| Dec 31, 2003 | 561.90M | 55.35% |
| Dec 31, 2002 | 361.70M | 63.67% |
| Dec 31, 2001 | 221.00M | 27.60% |
View and export this data all the way back to 2001.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |